Statements (18)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
investigational drug |
| gptkbp:CASNumber |
1234015-54-3
|
| gptkbp:hasMolecularFormula |
C17H22N8O2
|
| gptkbp:hasUNII |
6Q1K1N0Q1F
|
| gptkbp:heldBy |
CDK inhibitor
|
| https://www.w3.org/2000/01/rdf-schema#label |
Voruciclib
|
| gptkbp:is_in_clinical_trials |
yes
|
| gptkbp:IUPACName |
2-((6-(4-(morpholin-4-yl)piperazin-1-yl)pyridin-3-yl)amino)pyrimidin-4(3H)-one
|
| gptkbp:PubChem_CID |
46209416
CHEMBL3544940 |
| gptkbp:synonym |
P1446A-05
|
| gptkbp:target |
gptkb:CDK9
gptkb:CDK4 gptkb:CDK6 |
| gptkbp:uses |
gptkb:cancer
|
| gptkbp:bfsParent |
gptkb:Servier_Pharmaceuticals
|
| gptkbp:bfsLayer |
7
|